Brief: Organogenesis Holdings Posts Q1 EPS Of $0.07
May 10 (Reuters) - Organogenesis Holdings Inc ORGO.O :
* . REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS
* Q1 EARNINGS PER SHARE $0.07
* SEES FY 2021 REVENUE $438 MILLION TO $454 MILLION
* Q1 REVENUE $102.6 MILLION VERSUS REFINITIV IBES ESTIMATE
OF
$87.6 MILLION
* Q1 EARNINGS PER SHARE ESTIMATE $-0.02 -- REFINITIV IBES
DATA
* FY2021 REVENUE VIEW $397.2 MILLION -- REFINITIV IBES DATA
* EXPECT GAAP NET INCOME POSITIVE FOR TWELVE MONTHS ENDED
DECEMBER
31, 2021
Source text for Eikon: ID:nGNX9wP8Kj
Further company coverage: ORGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers